M Pharmaceutical Inc. to Acquire FDA Approved, Innovative Infertility Treatment Through Acquisition of ToConceive LLC. - A Natural Conception Lubricant
M Pharmaceutical Inc., (the "Company" or "M Pharma"), is announcing that the Company has entered into a letter of intent to acquire from ToConceive LLC., a private pharmaceutical company, the rights to an FDA approved women's health product, used as a natural conception lubricant as an infertility treatment. This acquisition is subject to further due diligence and stock exchange approval, and would see the Company issue 20 million shares and agree to pay a 5% royalty on sales.
View full press release